Mouse Anti-Glucagon-like peptide-1 (GLP-1 (1-36) amide) Monoclonal Antibody, Unconjugated, Clone 9F8 from AntibodyShop A/S
Description:Glucagon-like peptide-1 (
GLP-1 (1-36) amide)...
Company:AntibodyShop A/S
Anti-GLP-1 (7-36) (Glucagon-like peptide-1), C-terminus amide-reactive Polyclonal Antibody, Unconjugated from CHEMICON
Description:Glucagon-like peptide-1(7-36) amide (
GLP-1), C-terminal reactive. Cross-reacts fully with
GLP-1(1-36) amide but shows <0.1% cross reactivity with the unamidated forms
GLP-1(7-37) and
GLP-1(1-37) or other related peptides such as h
GLP-2, glucagon, hGIP and VIP.SPECIES REACTIVITIES: Most mammalian species.
GLP-1 is identical in all mammalian species studied except guinea pig and presumably its S...
Company:CHEMICON
Mouse Anti-GLP-1 Monoclonal Antibody, Unconjugated, Clone HYB 147-12 from Santa Cruz Biotechnology, Inc.
Description:
GLP-1 (HYB 147-12)...
Company:Santa Cruz Biotechnology, Inc.
Mouse Anti-Human GLP Monoclonal Antibody, Unconjugated, Clone 1B7B4 from ProMab Biotechnologies, Inc.
Description:Monoclonal Antibody to
GLP Ni-NTA purified truncated recombinant
GLP expressed in E. Coli strain BL21 (DE3)...
Company:ProMab Biotechnologies, Inc.
Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog
Liraglutide, Brings Patients to A1c Target
New study demonstrates 75% of patients receiving highest doseachieves A1c with no associated hypoglycemia CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- According tofindings presented today at the 67th Scientific Sessions of theAmerican Diabetes Association (ADA) in Chicago, Illinois, theinvestigational treatment liraglutide, a once- daily dose of human
GLP-1 analog under development by...
Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery
of GLP-1 and PYY
- Study shows orally-delivered
GLP-1 is able to stimulate insulinrelease TARRYTOWN, N.Y., March 29, 2007 /PRNewswire-FirstCall/ --Emisphere Technologies, Inc. reported today results of two clinicalstudies conducted in collaboration with Professor ChristophBeglinger, M.D. Division of Gastroenterology and Hepatology,University Hospital Basel in Basel, Switzerland. The objective ofthe study...